Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 37.50
-0.35 (-0.92%)
Oct 22, 2026, 1:35 PM CST
Qing Song Health Market Cap
Qing Song Health has a market cap or net worth of 2.48 billion as of October 23, 2026. It is the 27,069th most valuable company in the world and the 1,522nd biggest in Taiwan. Its market cap has decreased by 26.47% in one year.
Market Cap
2.48B
Enterprise Value
2.80B
Revenue
1.21B
Global Rank
Country Rank
#1,522 Taiwan
PE Ratio
9.98
ChartMarket Cap Chart
Since December 27, 2022, Qing Song Health's market cap has increased from 2.32B to 2.48B, an increase of 6.95%. That is a compound annual growth rate of 1.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 2.48B | -40.38% |
| Dec 31, 2025 | 4.16B | -29.22% |
| Dec 31, 2024 | 5.88B | 28.33% |
| Dec 29, 2023 | 4.58B | 120.52% |
| Dec 30, 2022 | 2.08B | -10.44% |
| Dec 27, 2022 | 2.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 480.74B |
| Lin BioScience | 134.75B |
| Caliway Biopharmaceuticals | 114.79B |
| Heron Neutron Medical | 68.02B |
| Chunghwa Chemical Synthesis & Biotech | 2.58B |
| Merdury Biopharmaceutical | 2.53B |
| Allied Biotech | 2.52B |
| A Plus Biotechnology | 2.50B |